Elgavish Paramagnetics, Inc.

Birmingham, AL 35226

SBIR Award Summary

Total Number of Awards 14
Total Value of Awards $3.76MM
First Award Date 08/15/97
Most Recent Award Date 03/06/15

Key Personnel

Last Name Name Awards Contact
Hild Gabor Hild 1
Suranyi Pal Suranyi 3
Ruzsics Balazs Ruzsics 1
Kiss Pal P Kiss 1
Varga-Szemes Akos Varga-Szemes 5
Toth Levente Toth 1
Kirschner Robert Jozsef Kirschner 1
Elgavish Rotem Elgavish 1

14 Awards Won

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-09-081
Budget: 03/06/15 - 06/30/15

DESCRIPTION (provided by applicant): The overall goal of this project is to demonstrate the ability of our acute-myocardial-infarct- selective paramagnetic contrast agent, Gadolinium(ABE-DTTA), to differentiate between acute and chronic infarcts in a reliable manner using contrast-enhanced magnetic resonance imaging (ceMRI). In our Phase I data ...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-09-081
Budget: 07/01/13 - 06/30/14

DESCRIPTION (provided by applicant): The overall goal of this project is to demonstrate the ability of our acute-myocardial-infarct- selective paramagnetic contrast agent, Gadolinium(ABE-DTTA), to differentiate between acute and chronic infarcts in a reliable manner using contrast-enhanced magnetic resonance imaging (ceMRI). In our Phase I data ...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-09-081
Budget: 07/01/11 - 06/30/13

DESCRIPTION (provided by applicant): The overall goal of this project is to demonstrate the ability of our acute-myocardial-infarct- selective paramagnetic contrast agent, Gadolinium(ABE-DTTA), to differentiate between acute and chronic infarcts in a reliable manner using contrast-enhanced magnetic resonance imaging (ceMRI). In our Phase I data ...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-09-081
Budget: 09/22/10 - 06/30/11

DESCRIPTION (provided by applicant): The overall goal of this project is to demonstrate the ability of our acute-myocardial-infarct- selective paramagnetic contrast agent, Gadolinium(ABE-DTTA), to differentiate between acute and chronic infarcts in a reliable manner using contrast-enhanced magnetic resonance imaging (ceMRI). In our Phase I data ...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-06-121
Budget: 08/01/09 - 07/31/12

DESCRIPTION (provided by applicant): The overall goal of this Phase II project is to develop a novel R1-based method for MRI quantification of postinfarct myocardial viability using a commercially available contrast agent Gd(DTPA). The commercial embodiment of this method will be a software package that will convert a set of 2D cardiac MRI imag...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-06-21
Budget: 08/01/08 - 07/31/09

DESCRIPTION (provided by applicant): The overall goal of this Phase II project is to develop a novel R1-based method for MRI quantification of postinfarct myocardial viability using a commercially available contrast agent Gd(DTPA). The commercial embodiment of this method will be a software package that will convert a set of 2D cardiac MRI imag...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-80
Budget: 04/15/08 - 03/31/09

DESCRIPTION (provided by applicant): The overall goal of this project is to develop and commercialize a software package to be interfaced with commercial MRI scanners providing physicians with an immediately available diagnostic tool for noninvasive detection, lateralization, and quantification of epileptogenic tissue. This software would conve...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-06-21
Budget: 09/10/07 - 07/31/08

DESCRIPTION (provided by applicant): The overall goal of this Phase II project is to develop a novel R1-based method for MRI quantification of postinfarct myocardial viability using a commercially available contrast agent Gd(DTPA). The commercial embodiment of this method will be a software package that will convert a set of 2D cardiac MRI imag...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 09/28/06 - 12/31/07

DESCRIPTION (provided by applicant): Reliable diagnostic differentiation between acute and chronic myocardial infarcts would be of great benefit for cardiac surgeons and interventional cardiologists. Such differentiation could be used to make decisions about which vessels and in what order would be reopened or bypassed. MRI is an intrinsically n...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 05/15/06 - 10/31/07

DESCRIPTION (provided by applicant): The long term goal of this project is to establish the usefulness of a new infarct-avid, persistent contrast agent (PCA), Gd(ABE-DTTA), which due to its long lifetime in tissue allows construction of accurate relaxation-rate-enhancement(AR1)-based voxel-by-voxel viability maps of the acutely infarcted heart. ...

Load More